Tafenoquine is recommended as an alternative to primaquine (3.5 mg/kg total dose) for preventing relapses of P. vivax in patients ≥ 2years of age, who have ≥ 70% glucose-6-phosphate dehydrogenase (G6PD) activity and who receive chloroquine treatment.